1. Home
  2. APAM vs IDYA Comparison

APAM vs IDYA Comparison

Compare APAM & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Artisan Partners Asset Management Inc.

APAM

Artisan Partners Asset Management Inc.

HOLD

Current Price

$36.08

Market Cap

2.6B

Sector

Finance

ML Signal

HOLD

Logo IDEAYA Biosciences Inc.

IDYA

IDEAYA Biosciences Inc.

HOLD

Current Price

$32.65

Market Cap

2.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
APAM
IDYA
Founded
1994
2015
Country
United States
United States
Employees
N/A
145
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.9B
IPO Year
2011
2019

Fundamental Metrics

Financial Performance
Metric
APAM
IDYA
Price
$36.08
$32.65
Analyst Decision
Buy
Strong Buy
Analyst Count
4
16
Target Price
$47.00
$51.21
AVG Volume (30 Days)
610.5K
733.9K
Earning Date
04-28-2026
05-05-2026
Dividend Yield
10.75%
N/A
EPS Growth
10.66
61.90
EPS
4.05
N/A
Revenue
$1,196,688,000.00
$218,710,000.00
Revenue This Year
$7.55
N/A
Revenue Next Year
$5.21
$213.03
P/E Ratio
$8.90
N/A
Revenue Growth
7.63
3024.43
52 Week Low
$32.75
$13.45
52 Week High
$48.46
$39.28

Technical Indicators

Market Signals
Indicator
APAM
IDYA
Relative Strength Index (RSI) 31.06 46.44
Support Level $35.02 $29.15
Resistance Level $45.09 $33.64
Average True Range (ATR) 0.98 1.35
MACD -0.10 -0.00
Stochastic Oscillator 18.43 31.85

Price Performance

Historical Comparison
APAM
IDYA

About APAM Artisan Partners Asset Management Inc.

Artisan Partners Asset Management Inc is a investment management firm providing a range of investment strategies to a diverse group of clients around the world. Each of the company's strategies is managed by one of its several investment teams. Investment management services are offered to institutions through separate accounts and mutual funds. Artisan's investment offerings include several long-only, equity investment strategies across a multitude of market capitalization segments and investing styles in both the United States and international markets. The company operates as one segment in the investment management business. The company generates maximum portion of its revenues from clients domiciled in countries outside the United States.

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275 (Werner Helicase), IDE161 (PARG), and IDE705 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

Share on Social Networks: